Cost Utility of Tumour Necrosis Factor-α Inhibitors for Rheumatoid Arthritis
Etanercept+MTX was a cost-effective treatment strategy in the base-case scenario; however, the model was sensitive to parameter uncertainties and ACR response criteria. Although Bayesian methods were used to determine transition probabilities, future studies will need to focus on head-to-head comparisons of multiple TNF-α inhibitors to provide valid comparisons. </AbstractSection> Copyright Springer International Publishing AG 2012
Year of publication: |
2012
|
---|---|
Authors: | Nguyen, Christine ; Bounthavong, Mark ; Mendes, Margaret ; Christopher, Melissa ; Tran, Josephine ; Kazerooni, Rashid ; Morreale, Anthony |
Published in: |
PharmacoEconomics. - Springer, ISSN 1170-7690. - Vol. 30.2012, 7, p. 575-593
|
Publisher: |
Springer |
Saved in:
Online Resource
Saved in favorites
Similar items by person
-
Bounthavong, Mark, (2012)
-
Nguyen, Christine M., (2012)
-
Bounthavong, Mark, (2012)
- More ...